Genetically modified T-cell therapy in multicenter trials

Cell Therapy in the Treatment of Solid TumorsПодробнее

Incysus enters clinical trial for genetically-modified T cells for treating glioblastomaПодробнее

Dr. Renier Brentjens on Genetically-Modified T CellsПодробнее

Late-Breaking Abstract: First-in-Man Trial of CAR T Cells in MyelomaПодробнее

Cell Therapy Solutions – Gene modified T cell workflowПодробнее

New clinical trial of boosted CAR T-cells for neuroblastomaПодробнее

Engineered T cells for Cancer Therapy in 2018 - Saar GillПодробнее

Challenges with ATMP clinical trials in EuropeПодробнее

Down with Cancer - Change the reality you're inПодробнее

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphomaПодробнее

Clinical Trials Are Key in the Evolution of CAR-T Cell Therapy in Multiple MyelomaПодробнее

Genetic engineering approaches to support clinical applications of T cell receptor library targetingПодробнее

T-Cell Therapies - Catherine Bollard, MD | Pediatric Grand RoundsПодробнее

CAR T-cell therapy: Mayo Clinic RadioПодробнее

The CAR T cell revolution in cancer therapyПодробнее

Engineering T‐Cells for Cancer Therapy: Challenges and OpportunitiesПодробнее

CAR-T gives sustained disease control in R/R adult DLBCL: updated JULIET analysisПодробнее

RTX-240: allogeneic RBCs drive expansion & trafficking of CD8+ T-cells & NK cells into the TMEПодробнее

History of CAR Approval and Next Generation CARs - Carl JuneПодробнее